128 related articles for article (PubMed ID: 11880187)
1. Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenografts.
Harris SR; Schoeffner DJ; Yoshiji H; Thorgeirsson UP
Cancer Lett; 2002 May; 179(1):95-101. PubMed ID: 11880187
[TBL] [Abstract][Full Text] [Related]
2. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells.
Ambs S; Merriam WG; Ogunfusika MO; Bennett WP; Ishibe N; Hussain SP; Tzeng EE; Geller DA; Billiar TR; Harris CC
Nat Med; 1998 Dec; 4(12):1371-6. PubMed ID: 9846573
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production.
Konopka TE; Barker JE; Bamford TL; Guida E; Anderson RL; Stewart AG
Cancer Res; 2001 Apr; 61(7):3182-7. PubMed ID: 11306506
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system.
Koistinen P; Siitonen T; Mäntymaa P; Säily M; Kinnula V; Savolainen ER; Soini Y
Leukemia; 2001 Sep; 15(9):1433-41. PubMed ID: 11516104
[TBL] [Abstract][Full Text] [Related]
5. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.
Fukumura D; Gohongi T; Kadambi A; Izumi Y; Ang J; Yun CO; Buerk DG; Huang PL; Jain RK
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2604-9. PubMed ID: 11226286
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells.
Yoshiji H; Harris SR; Thorgeirsson UP
Cancer Res; 1997 Sep; 57(18):3924-8. PubMed ID: 9307273
[TBL] [Abstract][Full Text] [Related]
8. Induction of angiogenesis by expression of soluble type II transforming growth factor-beta receptor in mouse hepatoma.
Kim KY; Jeong SY; Won J; Ryu PD; Nam MJ
J Biol Chem; 2001 Oct; 276(42):38781-6. PubMed ID: 11457844
[TBL] [Abstract][Full Text] [Related]
9. VEGF modulates NO production: the basis of a cytoprotective effect?
Servos S; Zachary I; Martin JF
Cardiovasc Res; 1999 Mar; 41(3):509-10. PubMed ID: 10435021
[No Abstract] [Full Text] [Related]
10. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E
Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671
[TBL] [Abstract][Full Text] [Related]
11. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells.
Yoshiji H; Kuriyama S; Yoshii J; Yamazaki M; Kikukawa M; Tsujinoue H; Nakatani T; Fukui H
Hepatology; 1998 Dec; 28(6):1489-96. PubMed ID: 9828211
[TBL] [Abstract][Full Text] [Related]
13. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
Zhang HT; Craft P; Scott PA; Ziche M; Weich HA; Harris AL; Bicknell R
J Natl Cancer Inst; 1995 Feb; 87(3):213-9. PubMed ID: 7535859
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells.
Bouloumié A; Schini-Kerth VB; Busse R
Cardiovasc Res; 1999 Mar; 41(3):773-80. PubMed ID: 10435050
[TBL] [Abstract][Full Text] [Related]
16. Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III).
Ludwig HC; Ahkavan-Shigari R; Rausch S; Schallock K; Quentin C; Ziegler D; Bockermann V; Markakis E
Anticancer Res; 2000; 20(1A):305-10. PubMed ID: 10769672
[TBL] [Abstract][Full Text] [Related]
17. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF.
Jozkowicz A; Cooke JP; Guevara I; Huk I; Funovics P; Pachinger O; Weidinger F; Dulak J
Cardiovasc Res; 2001 Sep; 51(4):773-83. PubMed ID: 11530111
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
Józkowicz A; Pankiewicz J; Dulak J; Partyka L; Wybrańska I; Huk I; Dembińska-Kieć A
Acta Biochim Pol; 1999; 46(3):703-15. PubMed ID: 10698278
[TBL] [Abstract][Full Text] [Related]
19. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide.
Scalia R; Booth G; Lefer DJ
FASEB J; 1999 Jun; 13(9):1039-46. PubMed ID: 10336886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
